Anti-HSPC150/UBE2T antibody [EP9447]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(6 Publications)
Rabbit Recombinant Monoclonal HSPC150/UBE2T antibody. Suitable for IP, Flow Cyt (Intra), WB, ICC/IF and reacts with Human samples. Cited in 6 publications.
View Alternative Names
HSPC150, PIG50, UBE2T, Ubiquitin-conjugating enzyme E2 T, Cell proliferation-inducing gene 50 protein, E2 ubiquitin-conjugating enzyme T, Ubiquitin carrier protein T, Ubiquitin-protein ligase T
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-HSPC150/UBE2T antibody [EP9447] (AB179802)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized HeLa cells labelling HSPC150/UBE2T with ab179802 at 1/50 (2 ug/ml) dilution, followed by AlexaFluor® 488-conjugated Goat anti-Rabbit secondary antibody (ab150081) at 1/1000 dilution at RT for 45 min. (Green).
Confocal image showing nuclear staining in HeLa cells (shown in green). ab195889 AlexaFluor® 594-conjugated Anti-alpha Tubulin, used as a counterstain at 1/200 dilution, was co-incubated with ab179802 overnight at 4° C. Nuclear DNA was labeled with DAPI (shown in blue).
Secondary antibody only control : Secondary antibody is AlexaFluor® 488-conjugated Goat anti-Rabbit secondary antibody (ab150081) at 1/1000 dilution.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-HSPC150/UBE2T antibody [EP9447] (AB179802)
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized HeLa cells labelling HSPC150/UBE2T with ab179802 at 1/20 dilution (5 ug/ml).
Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150081) was used as a secondary antibody.
- IP
Lab
Immunoprecipitation - Anti-HSPC150/UBE2T antibody [EP9447] (AB179802)
HSPC150/UBE2T was immunoprecipitated from 0.35 mg HeLa whole cell lysate with ab179802 at 1/20 dilution (0.5ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab179802 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used as secondary antibody at 1/5000 dilution.
All lanes:
Immunoprecipitation - Anti-HSPC150/UBE2T antibody [EP9447] (ab179802) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell), whole cell lysate at 10 µg
Lane 2:
HeLa cell lysate
Lane 3:
Rabbit monoclonal IgG (<a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a>) instead of ab179802 in HeLa whole cell lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Predicted band size: 23 kDa
false
Exposure time: 15s
- WB
Lab
Western blot - Anti-HSPC150/UBE2T antibody [EP9447] (AB179802)
An approximately 19 kDa band is observed but we are not sure how do define it
ab181602 was used as a GAPDH loading control.
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-HSPC150/UBE2T antibody [EP9447] (ab179802) at 1/10000 dilution
Lane 1:
A375 (Human malignant melanoma epithelial cell) whole cell lysate at 15 µg
Lane 2:
U-87 MG (Human glioblastoma-astrocytoma epithelial cell) whole cell lysate at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 23 kDa
true
Exposure time: 180s
Related conjugates and formulations (1)
-
Anti-HSPC150/UBE2T antibody [EP9447] - BSA and Azide free
Reactivity data
Product details
The production method for this product has been changed from hybridoma to recombinant on 15th April 2024.
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
HSPC150/UBE2T interacts with the Fanconi anemia (FA) complex playing a significant role within DNA repair processes. Its activity is necessary for mono-ubiquitination of the FANCD2 protein a central component of the FA pathway. Through this engagement UBE2T contributes to the repair of interstrand crosslinks in DNA therefore supporting the maintenance of genomic integrity. The protein's involvement in these processes highlights its importance in preserving proper cellular functions and preventing genomic instability.
Pathways
HSPC150/UBE2T is mainly involved in the DNA damage repair pathways particularly the Fanconi anemia pathway. In this context it collaborates with proteins like FANCL and RAD51 which are key players in homologous recombination and DNA repair. Ubiquitination of FANCD2 by UBE2T integrates into these pathways facilitating efficient DNA repair and ensuring cell survival following genotoxic stress.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
Journal of clinical laboratory analysis 37:e24781 PubMed36550019
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 48: PubMed35703356
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cancer letters 494:121-131 PubMed32590022
2020
Applications
Unspecified application
Species
Unspecified reactive species
Aging 12:10275-10289 PubMed32491994
2020
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 20:1462-1468 PubMed32724389
2020
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 12:4485-4492 PubMed28101210
2016
Applications
WB
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com